Protein homeostasis and aging in neurodegeneration

Journal of Cell Biology

Volumn 190, Issue 5, 2010, Pages 719-729

  Douglas, Peter M ^a   Dillin, Andrew ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK TRANSCRIPTION FACTOR 1; PROTEOME; SIRTUIN; SOMATOMEDIN C;

METABOLISM; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEIN TERTIARY STRUCTURE; REVIEW; RISK FACTOR;

AGING; ANIMALS; CELLS; HOMEOSTASIS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NERVE DEGENERATION; PROTEINS; SIGNAL TRANSDUCTION;

EID: 77956362155     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201005144     Document Type: Review

References (144)

1. Alonso, A.C., T. Zaidi, I. Grundke-Iqbal, and K. Iqbal. 1994. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:5562-5566. doi:10.1073/pnas.91.12.5562
2. Alonso, A.C., I. Grundke-Iqbal, and K. Iqbal. 1996. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2:783-787. doi:10.1038/nm0796-783
3. Alvira, D., M. Yeste-Velasco, J. Folch, E. Verdaguer, A.M. Canudas, M. Pallàs, and A. Camins. 2007. Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience. 147:746-756. doi:10.1016/j.neuroscience.2007.04.029
4. Alzheimer, A., R.A. Stelzmann, H.N. Schnitzlein, and F.R. Murtagh. 1995. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin. Anat. 8:429-431. doi:10.1002/ca.980080612
5. Arrasate, M., S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner. 2004. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 431:805-810. doi:10.1038/nature02998
6. Arriagada, P.V., J.H. Growdon, E.T. Hedley-Whyte, and B.T. Hyman. 1992. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:631-639.
7. Arum, O., M.S. Bonkowski, J.S. Rocha, and A. Bartke. 2009. The growth hormone receptor gene-disrupted mouse fails to respond to an intermittent fasting diet. Aging Cell. 8:756-760. doi:10.1111/j.1474-9726.2009.00520.x
8. Balch, W.E., R.I. Morimoto, A. Dillin, and J.W. Kelly. 2008. Adapting proteostasis for disease intervention. Science. 319:916-919. doi:10.1126/science.1141448
9. Bass, T.M., D. Weinkove, K. Houthoofd, D. Gems, and L. Partridge. 2007. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech. Ageing Dev. 128:546-552. doi:10.1016/j.mad.2007.07.007
10. Baur, J.A., K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, V.V. Prabhu, J.S. Allard, G. Lopez-Lluch, K. Lewis, et al. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 444:337-342. doi:10.1038/nature05354
11. Behrends, C., C.A. Langer, R. Boteva, U.M. Böttcher, M.J. Stemp, G. Schaffar, B.V. Rao, A. Giese, H. Kretzschmar, K. Siegers, and F.U. Hartl. 2006. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol. Cell. 23:887-897. doi:10.1016/j.molcel.2006.08.017
12. Ben-Zvi, A., E.A. Miller, and R.I. Morimoto. 2009. Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc. Natl. Acad. Sci. USA. 106:14914-14919. doi:10.1073/pnas.0902882106
13. Bennett, D.A., J.A. Schneider, R.S. Wilson, J.L. Bienias, and S.E. Arnold. 2004. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol. 61:378-384. doi:10.1001/archneur.61.3.378
14. Berdichevsky, A., M. Viswanathan, H.R. Horvitz, and L. Guarente. 2006. C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell. 125:1165-1177. doi:10.1016/j.cell.2006.04.036
15. Berger, Z., B. Ravikumar, F.M. Menzies, L.G. Oroz, B.R. Underwood, M.N. Pangalos, I. Schmitt, U. Wullner, B.O. Evert, C.J. O'Kane, and D.C. Rubinsztein. 2006. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 15:433-442. doi:10.1093/hmg/ddi458
16. Berger, Z., H. Roder, A. Hanna, A. Carlson, V. Rangachari, M. Yue, Z. Wszolek, K. Ashe, J. Knight, D. Dickson, et al. 2007. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27:3650-3662. doi:10.1523/JNEUROSCI.0587-07.2007
17. Bieschke, J., J. Russ, R.P. Friedrich, D.E. Ehrnhoefer, H. Wobst, K. Neugebauer, and E.E. Wanker. 2010. EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. USA. 107:7710-7715. doi:10.1073/pnas.0910723107
18. Binder, L.I., A. Frankfurter, and L.I. Rebhun. 1985. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101:1371-1378. doi:10.1083/jcb.101.4.1371
19. Bishop, N.A., and L. Guarente. 2007. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat. Rev. Genet. 8:835-844. doi:10.1038/nrg2188
20. Blüher, M., B.B. Kahn, and C.R. Kahn. 2003. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science. 299:572-574. doi:10.1126/science.1078223
21. Bodner, R.A., T.F. Outeiro, S. Altmann, M.M. Maxwell, S.H. Cho, B.T. Hyman, P.J. McLean, A.B. Young, D.E. Housman, and A.G. Kazantsev. 2006. Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc. Natl. Acad. Sci. USA. 103:4246-4251. doi:10.1073/pnas.0511256103
22. Bossy-Wetzel, E., R. Schwarzenbacher, and S.A. Lipton. 2004. Molecular pathways to neurodegeneration. Nat. Med. 10:S2-S9. doi:10.1038/nm1067
23. Brunn, G.J., C.C. Hudson, A. Sekulić, J.M. Williams, H. Hosoi, P.J. Houghton, J.C. Lawrence Jr., and R.T. Abraham. 1997. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science. 277:99-101. doi:10.1126/science.277.5322.99
24. Büeler, H., A. Aguzzi, A. Sailer, R.A. Greiner, P. Autenried, M. Aguet, and C. Weissmann. 1993. Mice devoid of PrP are resistant to scrapie. Cell. 73:1339-1347. doi:10.1016/0092-8674(93)90360-3
25. Carrell, R.W., and D.A. Lomas. 1997. Conformational disease. Lancet. 350:134-138. doi:10.1016/S0140-6736(97)02073-4
26. Caughey, B., and P.T. Lansbury. 2003. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26:267-298. doi:10.1146/annurev.neuro. 26.010302.081142
27. Chen, D., A.D. Steele, G. Hutter, J. Bruno, A. Govindarajan, E. Easlon, S.J. Lin, A. Aguzzi, S. Lindquist, and L. Guarente. 2008. The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Exp. Gerontol. 43:1086-1093. doi:10.1016/j.exger.2008.08.050
28. Chen, D., E.L. Thomas, and P. Kapahi. 2009. HIF-1 modulates dietary restriction-mediated lifespan extension via IRE-1 in Caenorhabditis elegans. PLoS Genet. 5:e1000486. doi:10.1371/journal.pgen.1000486
29. Cheng, I.H., K. Scearce-Levie, J. Legleiter, J.J. Palop, H. Gerstein, N. Bien-Ly, J. Puoliväli, S. Lesné, K.H. Ashe, P.J. Muchowski, and L. Mucke. 2007. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J. Biol. Chem. 282:23818-23828. doi:10.1074/jbc.M701078200
30. Chui, D.H., H. Tanahashi, K. Ozawa, S. Ikeda, F. Checler, O. Ueda, H. Suzuki, W. Araki, H. Inoue, K. Shirotani, et al. 1999. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat. Med. 5:560-564. doi:10.1038/8438
31. Cohen, E., J. Bieschke, R.M. Perciavalle, J.W. Kelly, and A. Dillin. 2006. Opposing activities protect against age-onset proteotoxicity. Science. 313:1604-1610. doi:10.1126/science.1124646
32. Cohen, E., J.F. Paulsson, P. Blinder, T. Burstyn-Cohen, D. Du, G. Estepa, A. Adame, H.M. Pham, M. Holzenberger, J.W. Kelly, et al. 2009. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell. 139:1157-1169. doi:10.1016/j.cell.2009.11.014
33. Collinge, J., F. Owen, M. Poulter, M. Leach, T.J. Crow, M.N. Rossor, J. Hardy, M.J. Mullan, I. Janota, and P.L. Lantos. 1990. Prion dementia without characteristic pathology. Lancet. 336:7-9. doi:10.1016/0140-6736(90)91518-F
34. Colman, R.J., R.M. Anderson, S.C. Johnson, E.K. Kastman, K.J. Kosmatka, T.M. Beasley, D.B. Allison, C. Cruzen, H.A. Simmons, J.W. Kemnitz, and R. Weindruch. 2009. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 325:201-204. doi:10.1126/science.1173635
35. Dauer, W., and S. Przedborski. 2003. Parkinson's disease: mechanisms and models. Neuron. 39:889-909. doi:10.1016/S0896-6273(03)00568-3
36. DiFiglia, M., E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, J.P. Vonsattel, and N. Aronin. 1997. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1990-1993. doi:10.1126/science.277.5334.1990
37. Douglas, P.M., S. Treusch, H.Y. Ren, R. Halfmann, M.L. Duennwald, S. Lindquist, and D.M. Cyr. 2008. Chaperone-dependent amyloid assembly protects cells from prion toxicity. Proc. Natl. Acad. Sci. USA. 105:7206-7211. doi:10.1073/pnas.0802593105
38. Douglas, P.M., D.W. Summers, and D.M. Cyr. 2009. Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways. Prion. 3:51-58. doi:10.4161/pri.3.2.8587
39. Drechsel, D.N., A.A. Hyman, M.H. Cobb, and M.W. Kirschner. 1992. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell. 3:1141-1154.
40. Duan, W., and M.P. Mattson. 1999. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57:195-206. doi:10.1002/(SICI)1097-4547(19990715)57:2〈195::AID-JNR5〉3. 0.CO;2-P
41. Esch, F.S., P.S. Keim, E.C. Beattie, R.W. Blacher, A.R. Culwell, T. Oltersdorf, D. McClure, and P.J. Ward. 1990. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 248:1122-1124. doi:10.1126/science.2111583
42. Evans, D.S., P. Kapahi, W.C. Hsueh, and L. Kockel. 2010. TOR signaling never gets old: Aging, longevity and TORC1 activity. Ageing Res. Rev. 10.1016/j.arr.2010.04.001.
43. Farzan, M., C.E. Schnitzler, N. Vasilieva, D. Leung, and H. Choe. 2000. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc. Natl. Acad. Sci. USA. 97:9712-9717. doi:10.1073/pnas.160115697
44. Feany, M.B., and W.W. Bender. 2000. A Drosophila model of Parkinson's disease. Nature. 404:394-398. doi:10.1038/35006074
45. Fiala, J.C. 2007. Mechanisms of amyloid plaque pathogenesis. Acta Neuropathol. 114:551-571. doi:10.1007/s00401-007-0284-8
46. Finch, C.E., and D.M. Cohen. 1997. Aging, metabolism, and Alzheimer disease: review and hypotheses. Exp. Neurol. 143:82-102. doi:10.1006/exnr.1996. 6339
47. Fowler, D.M., A.V. Koulov, C. Alory-Jost, M.S. Marks, W.E. Balch, and J.W. Kelly. 2006. Functional amyloid formation within mammalian tissue. PLoS Biol. 4:e6. doi:10.1371/journal.pbio.0040006
48. Freude, S., M.M. Hettich, C. Schumann, O. Stöhr, L. Koch, C. Köhler, M. Udelhoven, U. Leeser, M. Müller, N. Kubota, et al. 2009. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease. FASEB J. 23:3315-3324. doi:10.1096/fj.09-132043
49. Gidalevitz, T., A. Ben-Zvi, K.H. Ho, H.R. Brignull, and R.I. Morimoto. 2006. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science. 311:1471-1474. doi:10.1126/science.1124514
50. Glenner, G.G., and C.W. Wong. 1984. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-890. doi:10.1016/S0006-291X(84) 80190-4
51. Gong, C.X., F. Liu, I. Grundke-Iqbal, and K. Iqbal. 2005. Post-translational modifications of tau protein in Alzheimer's disease. J. Neural Transm. 112:813-838. doi:10.1007/s00702-004-0221-0
52. Greer, E.L., D. Dowlatshahi, M.R. Banko, J. Villen, K. Hoang, D. Blanchard, S.P. Gygi, and A. Brunet. 2007. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr. Biol. 17:1646-1656. doi:10.1016/j.cub.2007.08.047
53. Haass, C., and D.J. Selkoe. 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8:101-112. doi:10.1038/nrm2101
54. Haigis, M.C., and L.P. Guarente. 2006. Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20:2913-2921. doi:10.1101/gad.1467506
55. Hansen, M., S. Taubert, D. Crawford, N. Libina, S.J. Lee, and C. Kenyon. 2007. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell. 6:95-110. doi:10.1111/j.1474-9726.2006. 00267.x
56. Hara, T., K. Nakamura, M. Matsui, A. Yamamoto, Y. Nakahara, R. Suzuki- Migishima, M. Yokoyama, K. Mishima, I. Saito, H. Okano, and N. Mizushima. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 441:885-889. doi:10.1038/nature04724
57. Hardy, J. 2006. Amyloid double trouble. Nat. Genet. 38:11-12. doi:10.1038/ng0106-11
58. Harrison, D.E., R. Strong, Z.D. Sharp, J.F. Nelson, C.M. Astle, K. Flurkey, N.L. Nadon, J.E. Wilkinson, K. Frenkel, C.S. Carter, et al. 2009. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 460:392-395.
59. Hendrie, H.C., A. Ogunniyi, K.S. Hall, O. Baiyewu, F.W. Unverzagt, O. Gureje, S. Gao, R.M. Evans, A.O. Ogunseyinde, A.O. Adeyinka, et al. 2001. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 285:739-747. doi:10.1001/jama.285.6.739
60. Holzenberger, M., J. Dupont, B. Ducos, P. Leneuve, A. Géloën, P.C. Even, P. Cervera, and Y. Le Bouc. 2003. IGF-1 receptor regulates life-span and resistance to oxidative stress in mice. Nature. 421:182-187. doi:10.1038/nature01298
61. Honjoh, S., T. Yamamoto, M. Uno, and E. Nishida. 2009. Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C. elegans. Nature. 457:726-730. doi:10.1038/nature07583
62. Hsia, A.Y., E. Masliah, L. McConlogue, G.Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R.C. Malenka, R.A. Nicoll, and L. Mucke. 1999. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:3228-3233. doi:10.1073/pnas.96.6.3228
63. Hsu, A.L., C.T. Murphy, and C. Kenyon. 2003. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science. 300:1142-1145. doi:10.1126/science.1083701
64. Kaeberlein, M., M. McVey, and L. Guarente. 1999. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13:2570-2580. doi:10.1101/gad.13.19.2570
65. Kaeberlein, M., K.T. Kirkland, S. Fields, and B.K. Kennedy. 2004. Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol. 2:E296. doi:10.1371/journal.pbio.0020296
66. Kaeberlein, M., D. Hu, E.O. Kerr, M. Tsuchiya, E.A. Westman, N. Dang, S. Fields, and B.K. Kennedy. 2005a. Increased life span due to calorie restriction in respiratory-deficient yeast. PLoS Genet. 1:e69. doi:10.1371/journal.pgen. 0010069
67. Kaeberlein, M., R.W. Powers III, K.K. Steffen, E.A. Westman, D. Hu, N. Dang, E.O. Kerr, K.T. Kirkland, S. Fields, and B.K. Kennedy. 2005b. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 310:1193-1196. doi:10.1126/science.1115535
68. Kapahi, P., B.M. Zid, T. Harper, D. Koslover, V. Sapin, and S. Benzer. 2004. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 14:885-890. doi:10.1016/j.cub.2004.03.059
69. Kayed, R., E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:486-489. doi:10.1126/science.1079469
70. Kazlauskaite, J., A. Young, C.E. Gardner, J.V. Macpherson, C. Vénien-Bryan, and T.J. Pinheiro. 2005. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells. Biochem. Biophys. Res. Commun. 328:292-305. doi:10.1016/j.bbrc.2004.12. 172
71. Kenyon, C.J. 2010. The genetics of ageing. Nature. 464:504-512. doi:10.1038/nature08980
72. Kenyon, C., J. Chang, E. Gensch, A. Rudner, and R. Tabtiang. 1993. A C. elegans mutant that lives twice as long as wild type. Nature. 366:461-464. doi:10.1038/366461a0
73. Kidd, M. 1963. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature. 197:192-193. doi:10.1038/197192b0
74. Killick, R., G. Scales, K. Leroy, M. Causevic, C. Hooper, E.E. Irvine, A.I. Choudhury, L. Drinkwater, F. Kerr, H. Al-Qassab, et al. 2009. Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochem. Biophys. Res. Commun. 386:257-262. doi:10.1016/j.bbrc.2009.06.032
75. Kitamura, A., H. Kubota, C.G. Pack, G. Matsumoto, S. Hirayama, Y. Takahashi, H. Kimura, M. Kinjo, R.I. Morimoto, and K. Nagata. 2006. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat. Cell Biol. 8:1163-1170. doi:10.1038/ncb1478
76. Kuemmerle, S., C.A. Gutekunst, A.M. Klein, X.J. Li, S.H. Li, M.F. Beal, S.M. Hersch, and R.J. Ferrante. 1999. Huntington aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46:842-849. doi:10.1002/1531-8249(199912)46:6〈842::AID-ANA6〉3.0.CO;2-O
77. Kumar-Singh, S., I. Dewachter, D. Moechars, U. Lübke, C. De Jonghe, C. Ceuterick, F. Checler, A. Naidu, B. Cordell, P. Cras, et al. 2000. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol. Dis. 7:9-22. doi:10.1006/nbdi.1999.0272
78. Lee, I.H., L. Cao, R. Mostoslavsky, D.B. Lombard, J. Liu, N.E. Bruns, M. Tsokos, F.W. Alt, and T. Finkel. 2008. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. USA. 105:3374-3379. doi:10.1073/pnas.0712145105
79. Lin, S.J., P.A. Defossez, and L. Guarente. 2000. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 289:2126-2128. doi:10.1126/science.289.5487.2126
80. Liu, F., K. Iqbal, I. Grundke-Iqbal, G.W. Hart, and C.X. Gong. 2004. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 101:10804-10809. doi:10.1073/pnas.0400348101
81. Lo Bianco, C., J.L. Ridet, B.L. Schneider, N. Deglon, and P. Aebischer. 2002. alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl. Acad. Sci. USA. 99:10813-10818. doi:10.1073/pnas.152339799
82. Lotharius, J., and P. Brundin. 2002. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. Hum. Mol. Genet. 11:2395-2407. doi:10.1093/hmg/11.20.2395
83. Luchsinger, J.A., M.X. Tang, S. Shea, and R. Mayeux. 2002. Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 59:1258-1263. doi:10.1001/archneur.59.8.1258
84. Ma, X.M., and J. Blenis. 2009. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10:307-318. doi:10.1038/nrm2672
85. Mair, W., S.H. Panowski, R.J. Shaw, and A. Dillin. 2009. Optimizing dietary restriction for genetic epistasis analysis and gene discovery in C. elegans. PLoS One. 4:e4535. doi:10.1371/journal.pone.0004535
86. Marambaud, P., H. Zhao, and P. Davies. 2005. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem. 280:37377-37382. doi:10.1074/jbc.M508246200
87. Medori, R., P. Montagna, H.J. Tritschler, A. LeBlanc, P. Cortelli, P. Tinuper, E. Lugaresi, and P. Gambetti. 1992. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology. 42:669-670.
88. Mehta, R., K.A. Steinkraus, G.L. Sutphin, F.J. Ramos, L.S. Shamieh, A. Huh, C. Davis, D. Chandler-Brown, and M. Kaeberlein. 2009. Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science. 324:1196-1198. doi:10.1126/science.1173507
89. Moore, D.J., A.B. West, V.L. Dawson, and T.M. Dawson. 2005. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28:57-87. doi:10.1146/annurev.neuro.28.061604.135718
90. Morimoto, R.I. 2008. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 22:1427-1438. doi: 10.1101/gad.1657108
91. Morley, J.F., and R.I. Morimoto. 2004. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol. Biol. Cell. 15:657-664. doi:10.1091/mbc.E03-07-0532
92. Morley, J.F., H.R. Brignull, J.J. Weyers, and R.I. Morimoto. 2002. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 99:10417-10422. doi:10.1073/pnas.152161099
93. Moroi-Fetters, S.E., R.F. Mervis, E.D. London, and D.K. Ingram. 1989. Dietary restriction suppresses age-related changes in dendritic spines. Neurobiol. Aging. 10:317-322. doi:10.1016/0197-4580(89)90042-0
94. Moussa, C.E., C. Wersinger, Y. Tomita, and A. Sidhu. 2004. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Biochemistry. 43:5539-5550. doi:10.1021/bi036114f
95. Muchowski, P.J., and J.L. Wacker. 2005. Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 6:11-22. doi:10.1038/nrn1587
96. Nelson, R., M.R. Sawaya, M. Balbirnie, A.O. Madsen, C. Riekel, R. Grothe, and D. Eisenberg. 2005. Structure of the cross-beta spine of amyloid-like fibrils. Nature. 435:773-778. doi:10.1038/nature03680
97. Noda, T., and Y. Ohsumi. 1998. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273:3963-3966. doi:10.1074/jbc.273.7.3963
98. Nollen, E.A., S.M. Garcia, G. van Haaften, S. Kim, A. Chavez, R.I. Morimoto, and R.H. Plasterk. 2004. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc. Natl. Acad. Sci. USA. 101:6403-6408. doi:10.1073/pnas.0307697101
99. Outeiro, T.F., E. Kontopoulos, S.M. Altmann, I. Kufareva, K.E. Strathearn, A.M. Amore, C.B. Volk, M.M. Maxwell, J.C. Rochet, P.J. McLean, et al. 2007. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science. 317:516-519. doi:10.1126/science.1143780
100. Palazzolo, I., C. Stack, L. Kong, A. Musaro, H. Adachi, M. Katsuno, G. Sobue, J.P. Taylor, C.J. Sumner, K.H. Fischbeck, and M. Pennuto. 2009. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron. 63:316-328. doi:10.1016/j.neuron.2009.07. 019
101. Pallos, J., L. Bodai, T. Lukacsovich, J.M. Purcell, J.S. Steffan, L.M. Thompson, and J.L. Marsh. 2008. Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. Hum. Mol. Genet. 17:3767-3775. doi:10.1093/hmg/ddn273
102. Panowski, S.H., S. Wolff, H. Aguilaniu, J. Durieux, and A. Dillin. 2007. PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans. Nature. 447:550-555. doi:10.1038/nature05837
103. Park, J.C., K.C. Cook, and E.A. Verde. 1990. Dietary restriction slows the abnormally rapid loss of spiral ganglion neurons in C57BL/6 mice. Hear. Res. 48:275-279. doi:10.1016/0378-5955(90)90067-Y
104. Parker, J.A., M. Arango, S. Abderrahmane, E. Lambert, C. Tourette, H. Catoire, and C. Néri. 2005. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37:349-350. doi:10.1038/ng1534
105. Pearson, K.J., J.A. Baur, K.N. Lewis, L. Peshkin, N.L. Price, N. Labinskyy, W.R. Swindell, D. Kamara, R.K. Minor, E. Perez, et al. 2008. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 8:157-168. doi:10.1016/j.cmet.2008.06.011
106. Postina, R. 2008. A closer look at alpha-secretase. Curr. Alzheimer Res. 5:179-186. doi:10.2174/156720508783954668
107. Prusiner, S.B. 1998. Prions. Proc. Natl. Acad. Sci. USA. 95:13363-13383. doi:10.1073/pnas.95.23.13363
108. Qin, W., M. Chachich, M. Lane, G. Roth, M. Bryant, R. de Cabo, M.A. Ottinger, J. Mattison, D. Ingram, S. Gandy, and G.M. Pasinetti. 2006a. Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). J. Alzheimers Dis. 10:417-422.
109. Qin, W., T. Yang, L. Ho, Z. Zhao, J. Wang, L. Chen, W. Zhao, M. Thiyagarajan, D. MacGrogan, J.T. Rodgers, et al. 2006b. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281:21745-21754. doi:10.1074/jbc.M602909200
110. Ravikumar, B., R. Duden, and D.C. Rubinsztein. 2002. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11:1107-1117. doi:10.1093/hmg/11.9.1107
111. Ravikumar, B., C. Vacher, Z. Berger, J.E. Davies, S. Luo, L.G. Oroz, F. Scaravilli, D.F. Easton, R. Duden, C.J. O'Kane, and D.C. Rubinsztein. 2004. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36:585-595. doi:10.1038/ng1362
112. Reichel, W. 1966. The biology of aging. J. Am. Geriatr. Soc. 14:431-446.
113. Rincon, M., R. Muzumdar, G. Atzmon, and N. Barzilai. 2004. The paradox of the insulin/IGF-1 signaling pathway in longevity. Mech. Ageing Dev. 125:397-403. doi:10.1016/j.mad.2004.03.006
114. Rine, J., and I. Herskowitz. 1987. Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae. Genetics. 116:9-22.
115. Rogina, B., and S.L. Helfand. 2004. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA. 101:15998-16003. doi:10.1073/pnas.0404184101
116. Ross, C.A. 2002. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron. 35:819-822. doi:10.1016/S0896-6273(02)00872-3
117. Santacruz, K., J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, et al. 2005. Tau suppression in a neurodegenerative mouse model improves memory function. Science. 309:476-481. doi:10.1126/science.1113694
118. Saudou, F., S. Finkbeiner, D. Devys, and M.E. Greenberg. 1998. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:55-66. doi:10.1016/S0092-8674(00) 81782-1
119. Selkoe, D.J.; American College of Physicians; American Physiological Society. 2004. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140:627-638.
120. Shankar, G.M., S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, et al. 2008. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14:837-842. doi:10.1038/nm1782
121. Sherman, M.Y., and A.L. Goldberg. 2001. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron. 29:15-32. doi:10.1016/S0896-6273(01)00177-5
122. Shorter, J., and S. Lindquist. 2005. Prions as adaptive conduits of memory and inheritance. Nat. Rev. Genet. 6:435-450. doi:10.1038/nrg1616
123. Silveira, J.R., G.J. Raymond, A.G. Hughson, R.E. Race, V.L. Sim, S.F. Hayes, and B. Caughey. 2005. The most infectious prion protein particles. Nature. 437:257-261. doi:10.1038/nature03989
124. Simoneau, S., H. Rezaei, N. Salès, G. Kaiser-Schulz, M. Lefebvre-Roque, C. Vidal, J.G. Fournier, J. Comte, F. Wopfner, J. Grosclaude, et al. 2007. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog. 3:e125. doi:10.1371/journal.ppat.0030125
125. Singleton, A.B., M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nussbaum, et al. 2003. alpha-Synuclein locus triplication causes Parkinson's disease. Science. 302:841. doi:10.1126/science.1090278
126. Sisodia, S.S., and P.H. St George-Hyslop. 2002. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3:281-290. doi:10.1038/nrn785
127. Steinkraus, K.A., E.D. Smith, C. Davis, D. Carr, W.R. Pendergrass, G.L. Sutphin, B.K. Kennedy, and M. Kaeberlein. 2008. Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans. Aging Cell. 7:394-404. doi:10.1111/j.1474-9726.2008. 00385.x
128. Tain, L.S., H. Mortiboys, R.N. Tao, E. Ziviani, O. Bandmann, and A.J. Whitworth. 2009. Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat. Neurosci. 12:1129-1135. doi:10.1038/nn.2372
129. Tatar, M., A. Kopelman, D. Epstein, M.P. Tu, C.M. Yin, and R.S. Garofalo. 2001. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science. 292:107-110. doi:10.1126/science. 1057987
130. Tissenbaum, H.A., and L. Guarente. 2001. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 410:227-230. doi:10.1038/35065638
131. Tomiyama, T., S. Matsuyama, H. Iso, T. Umeda, H. Takuma, K. Ohnishi, K. Ishibashi, R. Teraoka, N. Sakama, T. Yamashita, et al. 2010. A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J. Neurosci. 30:4845-4856. doi:10.1523/JNEUROSCI.5825-09.2010
132. True, H.L., I. Berlin, and S.L. Lindquist. 2004. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature. 431:184-187. doi:10.1038/nature02885
133. van der Putten, H., K.H. Wiederhold, A. Probst, S. Barbieri, C. Mistl, S. Danner, S. Kauffmann, K. Hofele, W.P. Spooren, M.A. Ruegg, et al. 2000. Neuropathology in mice expressing human alpha-synuclein. J. Neurosci. 20:6021-6029.
134. van Ham, T.J., K.L. Thijssen, R. Breitling, R.M. Hofstra, R.H. Plasterk, and E.A. Nollen. 2008. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet. 4:e1000027. doi:10.1371/journal.pgen.1000027
135. van Leeuwen, F.W., D.P. de Kleijn, H.H. van den Hurk, A. Neubauer, M.A. Sonnemans, J.A. Sluijs, S. Köycü, R.D. Ramdjielal, A. Salehi, G.J. Martens, et al. 1998. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science. 279:242-247. doi:10.1126/science.279.5348.242
136. Vellai, T., K. Takacs-Vellai, Y. Zhang, A.L. Kovacs, L. Orosz, and F. Müller. 2003. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature. 426:620. doi:10.1038/426620a
137. Wang, J., L. Ho, W. Qin, A.B. Rocher, I. Seror, N. Humala, K. Maniar, G. Dolios, R. Wang, P.R. Hof, and G.M. Pasinetti. 2005. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J. 19:659-661. doi:10.1096/fj.04-2370com
138. Wang, T., U. Lao, and B.A. Edgar. 2009. TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease. J. Cell Biol. 186:703-711. doi:10.1083/jcb.200904090
139. Webb, J.L., B. Ravikumar, J. Atkins, J.N. Skepper, and D.C. Rubinsztein. 2003. Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278:25009-25013. doi:10.1074/jbc.M300227200
140. Weidemann, A., G. König, D. Bunke, P. Fischer, J.M. Salbaum, C.L. Masters, and K. Beyreuther. 1989. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell. 57:115-126. doi:10.1016/0092-8674(89)90177-3
141. Westerheide, S.D., J. Anckar, S.M. Stevens Jr., L. Sistonen, and R.I. Morimoto. 2009. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science. 323:1063-1066. doi:10.1126/science.1165946
142. Wolfe, M.S., W. Xia, B.L. Ostaszewski, T.S. Diehl, W.T. Kimberly, and D.J. Selkoe. 1999. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 398:513-517. doi:10.1038/19077
143. Wood, J.G., B. Rogina, S. Lavu, K. Howitz, S.L. Helfand, M. Tatar, and D. Sinclair. 2004. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 430:686-689. doi:10.1038/nature02789
144. Zoghbi, H.Y., and H.T. Orr. 2000. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23:217-247. doi:10.1146/annurev.neuro. 23.1.217